Characteristics and Risk Factors of Thrombotic Complications in Patients With Iron Deficiency Anemia [0.03%]
缺铁性贫血患者的血栓并发症的特点及危险因素
Ali Abdelfattah,Hebah Alarareh,Ghufran S Issa et al.
Ali Abdelfattah et al.
Background/objective: Although thromboses in association with iron deficiency anemia (IDA) have been reported in several case reports, comprehensive studies investigating the incidence, characteristics, and risk factors o...
Chen Nahshon,Ilana Grach,Eiman Shalabna et al.
Chen Nahshon et al.
Background: Mild thrombocytopenia is common in pregnancy and considered benign. However, its association with postpartum hemorrhage (PPH) remains unclear, with emerging evidence suggesting a potential increase in bleeding...
Platelet Transfusion in Patients With Low ADAMTS13-Confirmed Thrombotic Thrombocytopenic Purpura Is Associated With Increased Mortality [0.03%]
ADAMTS13验证的血小板减少性紫癜患者血小板输注与死亡率增加有关
Joseph O&#x;Brien,Alvin H Schmaier,Mayher J Patel et al.
Joseph O&#x;Brien et al.
Background: Thrombotic thrombocytopenic purpura (TTP) is a life-threatening thrombotic microangiopathy caused by severe ADAMTS13 deficiency. Platelet transfusions are generally contraindicated but are often administered b...
Healthcare Jurisdiction as a Determinant of Real-World Survival in Transplant-Ineligible Multiple Myeloma: Lessons From a Three-Country East Asian Comparison [0.03%]
移植 ineligible 多发性骨髓瘤患者的现实生存期受医疗管辖范围影响：来自东亚三国的对比研究带来的启示
Seonggyu Byeon,Sung-Soo Park,Seungpil Jung et al.
Seonggyu Byeon et al.
KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations [0.03%]
初诊MAPK通路基因突变的急性髓系白血病患者中，KRAS突变提示预后较差
Kensuke Takaoka,Sarah Mott,Ratdanai Yodsuwan et al.
Kensuke Takaoka et al.
Somatic mutations in the MAPK signaling pathway are frequently identified at AML diagnosis; however, their impact on treatment resistance and long-term survival remains unclear. We conducted a retrospective study of patients with newly diag...
Determinants of Immune Tolerance Induction Outcomes in 237 Persons With Severe Hemophilia A [0.03%]
146例重度甲型血友病患者免疫耐受诱导失败的危险因素分析
Marcus Fager Ferrari,Josefin Roslund,Eric Manderstedt et al.
Marcus Fager Ferrari et al.
Immune tolerance induction (ITI) to eradicate an immune response against factor VIII (FVIII) has been used in hemophilia A (HA) with various success rates, costs, and treatment burden. The present study aimed to identify markers predictive ...
DNMT3A and TET2 Mutations are Associated With Both Venous Thrombosis and Major Bleeding in Patients With Polycythemia Vera and Essential Thrombocythemia [0.03%]
DNA甲基化转移酶3α和双加氧酶2基因突变与真性红细胞增多症和原发性血小板增多症患者的静脉血栓形成及大出血相关性研究
Arnon Haran,Avital Wasserstrom,Vladimir Vainstein et al.
Arnon Haran et al.
Introduction: Thrombosis and bleeding events are major causes of morbidity and mortality in patients with myeloproliferative neoplasms (MPN). The contribution of non-driver mutations, in particular mutations in DNMT3A, TE...
Prognostic Validation of IPSS-M Versus ELN 2022/2024 in MDS/AML Patients: A Survival and Treatment Response Analysis [0.03%]
IPSS-M与ELN 2022/2024在MDS/AML患者中的预后验证：生存分析和治疗反应分析
Jianyu Hu,Xiao Shuai,Yong Guo et al.
Jianyu Hu et al.
Background: The 2022 International Consensus Classification (ICC) introduced myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) as a distinct entity for patients with 10%-19% marrow blasts lacking AML-defining gene...
Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network [0.03%]
糖尿病合并新诊断的慢性髓性白血病患者的酪氨酸激酶抑制剂选择及早期不良事件：意大利慢性粒细胞 leukemia 网络的真实生活调查
S Russo,I Capodanno,M Tiribelli et al.
S Russo et al.
Limited data are available regarding patients with newly diagnosed chronic myeloid leukemia (CML) and concomitant diabetes mellitus (DM). Hence, we retrospectively analyzed 2149 patients with newly diagnosed chronic phase (CP) CML to compar...
Mantle Cell Lymphoma in Geriatric Patients: Biologic Risk Stratification, Fitness-Adapted Strategies, and Unmet Needs [0.03%]
老年患者套细胞淋巴瘤的生物预后分层、适应体能状态的治疗策略及未满足需求
Victor M Samperio,Moza Hamoud,Ifeoma Ike et al.
Victor M Samperio et al.
Marked by significant biological and clinical heterogeneity, mantle cell lymphoma (MCL) in older adults represents a growing clinical challenge, driven by an aging population, increasing burden of comorbidities, and reduced tolerance to int...